Terrain Biosciences
Latest round
- Seed
Last raised
- Feb 2025
Total raised
- $9M
Investors
- 2
About Terrain Biosciences
Terrain Biosciences, Inc. is a biotechnology company that was founded in 2023 and is headquartered in Cambridge, US.Terrain Biosciences from Magnetic. Financial terms of the transaction were not disclosed.Terrain Bio specializes in RNA medicine development, offering a suite of products and services focused on optimizing RNA sequences for therapeutic applications. Their core offerings include a comprehensive AI/ML design suite that enables clients to tailor nucleotide sequences by enhancing manufacturability, stability, expression quality, immunogenicity, durability, and targetability. This technology is utilized in the design and production of messenger RNA (mRNA) sequences, catering to biopharmaceutical companies and research institutions aiming to expedite the drug discovery process. Terrain Bio's innovative manufacturing platform facilitates the production of mRNA at microgram to gram scales, ensuring high-quality outputs for rapid experimental iterations and translational studies.Terrain Bio's revenue model is built around B2B transactions, primarily engaging with biopharmaceutical companies that require customized mRNA solutions for their research and development efforts. The company operates through partnerships and direct contracts, where clients can access services such as custom-built RNA and catalog mRNA offerings. Pricing structures are tailored to the specific needs of clients based on the complexity and scale of the mRNA sequences required. Terrain Bio engages in negotiated agreements that outline service deliverables and project timelines, fostering long-term relationships with its partners in the biotech sector. While specific pricing details are not disclosed, the company's commitment to delivering high-quality RNA products positions it favorably in the competitive landscape of RNA therapeutics. The acquisition aims to expand its integrated platform by adding AI-enabled RNA design and manufacturing analytics to accelerate data-driven RNA therapeutic development.
Who invested in Terrain Biosciences
2 investors across 1 round
See all investors in Terrain Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 12, 2025
Amount
$9M
Investors
Questions about Terrain Biosciences
Who invested in Terrain Biosciences?
Terrain Biosciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Terrain Biosciences raised?
Terrain Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Terrain Biosciences last raise money?
Terrain Biosciences's most recent round on record is a Seed, in Feb 2025.
What does Terrain Biosciences do?
Terrain Biosciences is a biotechnology company.
Where is Terrain Biosciences headquartered?
Terrain Biosciences is headquartered in Cambridge, US.
Which VCs invest in companies like Terrain Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Terrain Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Terrain Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.